PharmAust specialises in the relaunch of existing marketed products for oncology applications making the whole development, regulatory and commercialisation process much faster. In addition, PharmAust's other wholly owned subsidiary, Epichem Pty Ltd generates sales of around $1.7M per annum from contract sales to the pharmaceutical industry of synthetic drugs.
2011年2月10日澳洲股市報告包括：Calzada (ASX:CZD)宣佈人類骨骼生長干細胞研究取得積極結果；PharmAust Limited (ASX:PAA)將收購歐洲高品位貴金屬和基礎金屬項目；Northern Star Resources (ASX:NST)宣布西澳黃金生產強勁結果；Latin Resources Limited (ASX:LRS)將收購秘魯14,068公頃的世界級鐵及重礦砂礦權地。
ABN Newswire今天的股票看點包括：iSOFT Group Limited (ASX:ISF)、AuDAX Resources Limited (ASX:ADX) (PINK:ADXRF)、Clean Global Energy Limited (ASX:CGV)和Brickworks Limited (ASX:BKW)。
